269 related articles for article (PubMed ID: 18486198)
1. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
[TBL] [Abstract][Full Text] [Related]
2. Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
Irish AB; Green FR
Nephrol Dial Transplant; 1998 Mar; 13(3):679-84. PubMed ID: 9550647
[TBL] [Abstract][Full Text] [Related]
3. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
5. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
[TBL] [Abstract][Full Text] [Related]
9. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
10. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
11. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
[TBL] [Abstract][Full Text] [Related]
12. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
[TBL] [Abstract][Full Text] [Related]
13. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
14. Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients.
Pawlak K; Borawski J; Naumnik B; Mysliwiec M
Thromb Res; 2003 Mar; 109(5-6):247-51. PubMed ID: 12818246
[TBL] [Abstract][Full Text] [Related]
15. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
[TBL] [Abstract][Full Text] [Related]
16. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
[TBL] [Abstract][Full Text] [Related]
17. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
[TBL] [Abstract][Full Text] [Related]
19. Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia.
Laine OK; Koskela SM; Outinen TK; Joutsi-Korhonen L; Huhtala H; Vaheri A; Hurme MA; Jylhävä J; Mäkelä SM; Mustonen JT
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):612-7. PubMed ID: 24751477
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure.
Mezzano D; Tagle R; Pais E; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
Thromb Res; 1997 Dec; 88(6):465-72. PubMed ID: 9610957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
